百时美施贵宝与Chai Discovery合作利用AI开发新疗法

格隆汇
Aug 20
百时美施贵宝正与Chai Discovery合作,利用人工智能开发基于抗体的新疗法。双方未披露财务条款。百时美施贵宝将利用Chai的AI模型和平台能力,包括其分子折叠与设计模型等。Chai表示,其模型通过根据既定标准生成分子并压缩药物发现周期,加速药物发现进程,从而探索传统发现方法一直难以触及的靶点。该公司已与礼来、辉瑞和诺华建立合作关系。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10